Intracutaneous Sterile Water and Diclofenac Sodium Injections in Renal Colic
Comparison Between Intracutaneous Sterile Water and Diclofenac Sodium Injections in Renal Colic: A Randomized Controlled Clinical Trial
1 other identifier
interventional
570
0 countries
N/A
Brief Summary
Renal colic is a serious and excruciatingly painful condition that frequently presents itself in the emergency department. In this trial, patients with renal colic who have received intramuscular diclofenac sodium injection or intracutaneous sterile water injection will have their Visual Analogue Scale (VAS) measured and compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedApril 2, 2024
March 1, 2024
6 months
March 19, 2024
March 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS)
Comparing the Visual Analogue Scale (VAS) between patients who had intramuscular diclofenac sodium injection and intracutaneous sterile water injection for the treatment of renal colic. One of the pain rating instruments that Hayes and Patterson used for the first time was the Visual Analogue Scale (VAS), introduced in 1921. A straight line represents the visual analog scale for pain, with zero representing no pain and ten representing the worst possible pain. A patient indicates on the line the location of the point that corresponds to their level of pain.
For 45 minutes, the VAS will be measured three times, at 15, 30, and 45 minutes of the procedure.
Study Arms (2)
Intracutaneous sterile water injection (ISWI)
ACTIVE COMPARATORSterile water will be intramuscularly injected in the intracutaneous sterile water injection (ISWI) group (Group I) in a plane parallel to the posterior midline, adhering to a predetermined injection pattern from the level of the iliac crest to the last rib.
Intramuscular diclofenac sodium injection (DIC)
ACTIVE COMPARATORDiclofenac sodium injection intramuscularly (Group II): Diclofenac sodium injection intramuscularly (75 mg) will be given to 285 patients in total.
Interventions
Injection of intracutaneous sterile water
Injection of intramuscular diclofenac sodium
Eligibility Criteria
You may qualify if:
- Patients between the ages of 18 and 65.
- Patients with renal colic at the emergency department of the 30 June Center for Urology and Nephrology, Ismailia, Egypt.
You may not qualify if:
- Cardiovascular diseases.
- Renal, and hepatic dysfunction.
- Hypersensitivity to any of the used drugs.
- Addiction or chronic use of opioids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor Suez Canal University Faculty of Medicine
Study Record Dates
First Submitted
March 19, 2024
First Posted
April 2, 2024
Study Start
May 1, 2024
Primary Completion
October 30, 2024
Study Completion
December 30, 2024
Last Updated
April 2, 2024
Record last verified: 2024-03